| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,444 |
1,934 |
$88K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,464 |
5,990 |
$71K |
| 99215 |
Prolong outpt/office vis |
2,867 |
2,375 |
$51K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
550 |
500 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
689 |
645 |
$8K |
| 99205 |
Prolong outpt/office vis |
236 |
234 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
253 |
250 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
271 |
260 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
187 |
157 |
$4K |
| 99402 |
|
98 |
91 |
$3K |
| 99386 |
|
137 |
134 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
299 |
169 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
76 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
30 |
29 |
$2K |
| 82948 |
|
501 |
412 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
27 |
27 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
14 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
96 |
48 |
$849.60 |
| 80305 |
|
71 |
69 |
$706.81 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
126 |
107 |
$580.43 |
| 99385 |
|
41 |
40 |
$547.68 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
47 |
47 |
$328.53 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
27 |
26 |
$243.09 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$169.36 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
30 |
14 |
$161.70 |
| 81000 |
|
63 |
62 |
$157.56 |
| 99050 |
|
17 |
15 |
$0.00 |